Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-02

FDA Approved: TYRVAYA — Supplemental Application (Oyster Point Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TYRVAYA (varenicline) from Oyster Point Pharma, expanding the regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tyrvaya (varenicline)

Snippet

SUPPL AP for TYRVAYA (VARENICLINE)